X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (49) 49
humans (36) 36
animals (34) 34
female (26) 26
clinical medicine (22) 22
medical and health sciences (22) 22
medicin och hälsovetenskap (22) 22
klinisk medicin (20) 20
male (20) 20
rats (20) 20
cancer and oncology (19) 19
cancer och onkologi (19) 19
endocrinology & metabolism (17) 17
gene expression (17) 17
obesity (17) 17
rats, sprague-dawley (15) 15
food-intake (14) 14
hypothalamus (14) 14
neurosciences (14) 14
pharmacology & pharmacy (14) 14
middle aged (13) 13
breast cancer (12) 12
hypothalamus - metabolism (12) 12
lipid metabolism (12) 12
mice (12) 12
research (12) 12
activated protein-kinase (11) 11
food intake (11) 11
homeostasis (11) 11
psychiatry (11) 11
adipose tissue, brown - metabolism (10) 10
adipose-tissue (10) 10
adult (10) 10
body-weight (10) 10
expression (10) 10
oncology (10) 10
physiological aspects (10) 10
abridged index medicus (9) 9
fatty-acid-metabolism (9) 9
induced weight-gain (9) 9
metabolism (9) 9
adipose-tissue thermogenesis (8) 8
biochemistry & molecular biology (8) 8
brown adipose-tissue (8) 8
energy balance (8) 8
energy-balance (8) 8
glucose (8) 8
insulin (8) 8
lipids (8) 8
liver (8) 8
liver - metabolism (8) 8
mice, inbred c57bl (8) 8
schizophrenia (8) 8
adipose tissue, brown - drug effects (7) 7
ampk (7) 7
analysis (7) 7
body weight (7) 7
cancer (7) 7
clinical neurology (7) 7
genetic aspects (7) 7
prognosis (7) 7
research article (7) 7
thermogenesis (7) 7
adipose tissue (6) 6
aged (6) 6
amp-activated protein kinases - metabolism (6) 6
antipsychotics (6) 6
biomarkers (6) 6
cell biology (6) 6
cells (6) 6
cholesterol (6) 6
clozapine (6) 6
energy metabolism (6) 6
energy metabolism - physiology (6) 6
fatty acids (6) 6
liver - drug effects (6) 6
multidisciplinary sciences (6) 6
obesity - metabolism (6) 6
rodents (6) 6
srebp (6) 6
weight gain - drug effects (6) 6
antipsychotic agents - pharmacology (5) 5
biology (5) 5
brain (5) 5
breast neoplasms - genetics (5) 5
dextrose (5) 5
eating - drug effects (5) 5
flow cytometry (5) 5
gene expression regulation - drug effects (5) 5
glucose metabolism (5) 5
internal medicine (5) 5
lipid metabolism - drug effects (5) 5
medicine (5) 5
olanzapine (5) 5
proteins (5) 5
rat (5) 5
receptor (5) 5
science (5) 5
thermogenesis - drug effects (5) 5
time factors (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes, ISSN 0012-1797, 10/2014, Volume 63, Issue 10, pp. 3346 - 3358
GLP-1 receptor (GLP-1R) is widely located throughout the brain, but the precise molecular mechanisms mediating the actions of GLP-1 and its long-acting analogs... 
NERVOUS-SYSTEM | GLUCOSE-HOMEOSTASIS | ENERGY-EXPENDITURE | GLUCAGON-LIKE PEPTIDE-1 | FOOD-INTAKE | ENDOCRINOLOGY & METABOLISM | WEIGHT-LOSS | RAT-BRAIN | DIET-INDUCED OBESITY | RECEPTORS | TYPE-2 DIABETES-MELLITUS | Protein Kinases - metabolism | Metformin - therapeutic use | Obesity - drug therapy | Humans | Middle Aged | Male | Diabetes Mellitus, Type 2 - metabolism | Eating - physiology | Young Adult | Glucagon-Like Peptide 1 - agonists | Aged, 80 and over | Adult | Female | Hypothalamus - drug effects | Drug Therapy, Combination | Energy Metabolism - physiology | Hypoglycemic Agents - therapeutic use | Glucagon-Like Peptide 1 - analogs & derivatives | Metformin - pharmacology | Glucagon-Like Peptide 1 - pharmacology | Rats | Hypoglycemic Agents - pharmacology | Obesity - metabolism | Peptides - pharmacology | Eating - drug effects | Animals | Hypothalamus - metabolism | Venoms - therapeutic use | Adipose Tissue, Brown - drug effects | Adipose Tissue, Brown - metabolism | Aged | Mice | Venoms - pharmacology | Thermogenesis - drug effects | Diabetes Mellitus, Type 2 - drug therapy | Energy Metabolism - drug effects | Liraglutide | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Type 2 diabetes | Complications and side effects | Thermogenesis | Body weight | Brown adipose tissue | Development and progression | Research | Risk factors
Journal Article
Journal of Endocrinology, ISSN 0022-0795, 2017, Volume 232, Issue 2, pp. 351 - 362
Journal Article
International Journal of Neuropsychopharmacology, ISSN 1461-1457, 2014, Volume 17, Issue 1, pp. 91 - 104
Journal Article
Reviews in Endocrine and Metabolic Disorders, ISSN 1389-9155, 11/2019
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2010, Volume 28, Issue 11, pp. 1813 - 1820
Journal Article
Psychopharmacology, ISSN 0033-3158, 2/2012, Volume 219, Issue 3, pp. 783 - 794
Journal Article
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 7/2011, Volume 25, Issue 7, pp. 924 - 933
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 6, p. e20571
The success of antipsychotic drug treatment in patients with schizophrenia is limited by the propensity of these drugs to induce hyperphagia, weight gain and... 
BODY-WEIGHT | CLOZAPINE | ACTIVATED PROTEIN-KINASE | LIPID-METABOLISM | ANTIPSYCHOTIC OLANZAPINE | HALOPERIDOL | FOOD-INTAKE | MULTIDISCIPLINARY SCIENCES | FATTY-ACID-METABOLISM | RATS | MODEL | AMP-Activated Protein Kinases - metabolism | Clozapine - administration & dosage | Injections, Intraventricular | Hyperphagia - chemically induced | Intracellular Signaling Peptides and Proteins - metabolism | Neuropeptide Y - genetics | Insulin - blood | Hyperphagia - blood | Aminoimidazole Carboxamide - pharmacology | Neuropeptide Y - metabolism | Ribonucleotides - pharmacology | Clozapine - pharmacology | Leptin - blood | Arcuate Nucleus of Hypothalamus - drug effects | Female | Weight Gain - drug effects | Hypothalamus - drug effects | Phosphorylation - drug effects | Pro-Opiomelanocortin - genetics | Benzodiazepines - pharmacology | Orexins | Aminoimidazole Carboxamide - administration & dosage | Arcuate Nucleus of Hypothalamus - metabolism | Rats | Neuropeptides - metabolism | Agouti-Related Protein - metabolism | Rats, Sprague-Dawley | Feeding Behavior - drug effects | Gene Expression Regulation - drug effects | Pro-Opiomelanocortin - metabolism | Ribonucleotides - administration & dosage | Animals | Aminoimidazole Carboxamide - analogs & derivatives | Signal Transduction - drug effects | Agouti-Related Protein - genetics | Hypothalamus - enzymology | Benzodiazepines - administration & dosage | Neuropeptide Y | Brain | Olanzapine | Schizophrenia | Clozapine | Intermedin | Patient compliance | Hyperphagia | Phosphorylation | Neuroleptics | Mental disorders | Arcuate nucleus | Homeostasis | Lipids | Neuropeptides | Proopiomelanocortin | Hypothalamus | Kinases | AMP-activated protein kinase | Proteins | Psychotropic drugs | Energy | Rodents | Physiology | Food | Free radicals | AMP | Metabolism | Body weight gain | Fatty acids | Medicine | Energy balance | Signaling | Brain research | Hospitals | Molecular modelling | Food intake | Weight reduction | Clinical medicine | Psychiatry | Endocrinology
Journal Article
BMC Cancer, ISSN 1471-2407, 09/2011, Volume 11, Issue 1, pp. 418 - 418
Journal Article